Study of Left Ventricular Remodelling in Patients with Chronic Obstructive Pulmonary Disease
International Journal of Drug Delivery Technology · 16.11.2026 · 16 (80s)
DOI: 10.25258/ijddt.16.80s.79 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 16.11.2026. Verfasst von Mrutyunjay B Hiregoudar und 3 weiteren Autor:innen.
Themen: COPD
Abstract (Originalsprache)
This study aims to quantify left ventricular remodelling and the prevalence of left ventricular hypertrophy in patients with chronic obstructive pulmonary disease devoid of cardiovascular disease. It was a hospital based cross sectional includes adult patients diagnosed with COPD belonging to all classes of GOLD criteria which includes both OPD and IPD cases at SDMCMS&H. Patients with CAD, cardiomyopathy, LBBB , heart failure, significant valvular dysfunction , chronic AF, pacemaker , hypertension higher than stage1 and IDDM were excluded. Sample size is 150 . Thorough history , clinical examination , ECG , chest xray , echocardiography done. In the echocardiography interventricular septal wall thickness(SWT), posterior wall thickness (PWT) , left ventricular end diastolic diameter (EDD) , LVH noted. LVM and RWT calculated using appropriate formula . Results: In the present study , we noted that the mean age in the study was 70.24 years. In that 62% were males and 28% were females with male to female ratio of 1.63:1 . The mean SWT was 11.36mm , mean PWT- 11.15mm , mean LVEDD- 39.15mm. The RWT was below 0.42 in 4.67% of patients and above 0.42 in 95.33% subjects. Of the remodelling types observed 2% exhibited eccentric LVH and 98% concentric LVH. The average LVM – 202.87. CONCLUSION: By evaluating LVM and RWT, we aimed to quantify LV remodeling and the prevalence of LVH in COPD. The majority (95.33%) had a relative wall thickness greater than 0.42, with a high sensitivity (94.3%) and specificity (95.2%). Most subjects (98%) exhibited concentric LVH, and the left ventricular mass averaged 202.87, ranging from 62.10 to 529.63. These findings highlight significant demographic, clinical, and cardiac characteristics of the study population.
Zitieren
APA
Hiregoudar, M. B., M, D., Gangaraddy, R., & R, S. (2026). Study of Left Ventricular Remodelling in Patients with Chronic Obstructive Pulmonary Disease. International Journal of Drug Delivery Technology, 16(80s). https://doi.org/10.25258/ijddt.16.80s.79
Vancouver
Hiregoudar MB, M D, Gangaraddy R, R S. Study of Left Ventricular Remodelling in Patients with Chronic Obstructive Pulmonary Disease. International Journal of Drug Delivery Technology. 2026;16(80s). doi:10.25258/ijddt.16.80s.79
BibTeX
@article{Hiregoudar2026,
author = {Hiregoudar, Mrutyunjay B and M, Dhananjaya and Gangaraddy, Raghavendra and R, Srinivas},
title = {Study of Left Ventricular Remodelling in Patients with Chronic Obstructive Pulmonary Disease},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {80s},
doi = {10.25258/ijddt.16.80s.79}
}
EUVIMED